Bernhard Zöllner

2.9k total citations
65 papers, 2.0k citations indexed

About

Bernhard Zöllner is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Bernhard Zöllner has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 35 papers in Epidemiology and 29 papers in Infectious Diseases. Recurrent topics in Bernhard Zöllner's work include Hepatitis C virus research (36 papers), Hepatitis B Virus Studies (30 papers) and HIV/AIDS drug development and treatment (15 papers). Bernhard Zöllner is often cited by papers focused on Hepatitis C virus research (36 papers), Hepatitis B Virus Studies (30 papers) and HIV/AIDS drug development and treatment (15 papers). Bernhard Zöllner collaborates with scholars based in Germany, Austria and United States. Bernhard Zöllner's co-authors include Rainer Laufs, Heinz‐Hubert Feucht, Matthias Schröter, Peter Schäfer, H.-H. Feucht, Susanne Polywka, Karsten Wursthorn, Peter Buggisch, Martina Sterneck and Marc Lütgehetmann and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Bernhard Zöllner

64 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard Zöllner Germany 23 1.4k 1.3k 566 201 163 65 2.0k
Jean‐Marie Huraux France 24 1.5k 1.0× 1.3k 0.9× 303 0.5× 204 1.0× 60 0.4× 46 2.1k
Moya Briggs United Kingdom 17 1.6k 1.1× 1.1k 0.8× 488 0.9× 134 0.7× 66 0.4× 37 2.0k
George G. Schlauder United States 19 1.7k 1.2× 2.9k 2.2× 1.4k 2.5× 157 0.8× 272 1.7× 33 3.3k
Jacqueline C. Melpolder United States 9 2.6k 1.9× 2.9k 2.2× 380 0.7× 207 1.0× 191 1.2× 11 3.4k
G. L. Toms United Kingdom 24 1.4k 1.0× 643 0.5× 522 0.9× 59 0.3× 89 0.5× 79 1.9k
K. Krawczyński United States 28 1.3k 0.9× 2.1k 1.6× 913 1.6× 81 0.4× 73 0.4× 48 2.6k
H. J. Alter United States 18 1.5k 1.1× 1.5k 1.2× 350 0.6× 332 1.7× 86 0.5× 36 2.2k
Yoshiki Sugai Japan 17 2.6k 1.8× 3.2k 2.4× 719 1.3× 54 0.3× 339 2.1× 34 3.6k
Benoît Callendret Netherlands 20 893 0.6× 432 0.3× 751 1.3× 99 0.5× 122 0.7× 49 1.6k
Hajime Tokita Japan 19 1.4k 1.0× 1.8k 1.3× 441 0.8× 41 0.2× 149 0.9× 42 2.0k

Countries citing papers authored by Bernhard Zöllner

Since Specialization
Citations

This map shows the geographic impact of Bernhard Zöllner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Zöllner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Zöllner more than expected).

Fields of papers citing papers by Bernhard Zöllner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Zöllner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Zöllner. The network helps show where Bernhard Zöllner may publish in the future.

Co-authorship network of co-authors of Bernhard Zöllner

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Zöllner. A scholar is included among the top collaborators of Bernhard Zöllner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Zöllner. Bernhard Zöllner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mack, Dietrich, et al.. (2022). The importance of effect sizes when comparing cycle threshold values of SARS-CoV-2 variants. PLoS ONE. 17(7). e0271808–e0271808.
2.
Bockmühl, Dirk P., et al.. (2021). Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study. Journal of Clinical Virology. 138. 104791–104791. 19 indexed citations
3.
Lütgehetmann, Marc, Karsten Wursthorn, Peter Buggisch, et al.. (2006). 508 48 Weeks of adefovir mono therapy following 48 weeks of combination therapy with peginterferon alpha-2b and adefovir leads to additional biochemical and virological improvement. Journal of Hepatology. 44. S189–S189. 1 indexed citations
4.
Zöllner, Bernhard, Heinz‐Hubert Feucht, Martina Sterneck, et al.. (2006). Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier. Liver Transplantation. 12(8). 1283–1289. 14 indexed citations
5.
Zöllner, Bernhard, Jörg Petersen, Elisabeth Puchhammer‐Stöckl, et al.. (2004). Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology. 39(1). 42–50. 99 indexed citations
6.
Krüger, William, Bernhard Zöllner, Paul-Michael Kaulfers, & Axel R. Zander. (2003). Effective Protection of Allogeneic Stem Cell Recipients Against Aspergillosis by HEPA Air Filtration During a Period of Construction—A Prospective Survey. Journal of Hematotherapy & Stem Cell Research. 12(3). 301–307. 16 indexed citations
7.
Schröter, Matthias, et al.. (2003). A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance. Journal of Clinical Virology. 27(1). 69–73. 21 indexed citations
8.
Fischer, Lutz, Martina Sterneck, Daniela Piani Meier, Bernhard Zöllner, & Xavier Rogiers. (2002). The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation. Transplantation Proceedings. 34(6). 2283–2284. 1 indexed citations
9.
Zöllner, Bernhard, Jörg Petersen, Peter Schäfer, et al.. (2002). Subtype‐Dependent Response of Hepatitis B Virus during the Early Phase of Lamivudine Treatment. Clinical Infectious Diseases. 34(9). 1273–1277. 44 indexed citations
10.
Schröter, Matthias, Heinz‐Hubert Feucht, Bernhard Zöllner, Peter Schäfer, & Rainer Laufs. (2001). Prevalence of a Novel DNA Virus (TTV) among Patients on Maintenance Hemodialysis. ˜The œNephron journals/Nephron journals. 87(2). 139–142. 4 indexed citations
11.
Schröter, Matthias, Peter Schäfer, Bernhard Zöllner, et al.. (2001). Strategies for reliable diagnosis of hepatitis C infection: The need for a serological confirmatory assay. Journal of Medical Virology. 64(3). 320–324. 13 indexed citations
12.
Zöllner, Bernhard, Albrecht Stoehr, Andreas Plettenberg, et al.. (2000). In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy — a clinical note. Journal of Clinical Virology. 17(3). 183–188. 9 indexed citations
13.
Fischer, Lutz, Martina Sterneck, Bernhard Zöllner, & Xavier Rogiers. (2000). Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation. Transplantation Proceedings. 32(7). 2128–2130. 7 indexed citations
14.
Meyer, Ulrich, et al.. (1999). Untersuchung von Patienten mit Gesichtsschädelfrakturen unter ätiologischen und rechtsrelevanten Gesichtspunkten. Mund- Kiefer- und Gesichtschirurgie. 3(3). 152–157. 18 indexed citations
15.
Feucht, Heinz‐Hubert, Bernhard Zöllner, Matthias Schröter, et al.. (1999). High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up. Journal of Clinical Virology. 13(1-2). 43–51. 7 indexed citations
16.
Schröter, Matthias, et al.. (1999). Low Risk of Vertical Transmission of Hepatitis C Virus by Breast Milk. Clinical Infectious Diseases. 29(5). 1327–1329. 50 indexed citations
17.
Jurinke, Christian, Bernhard Zöllner, Dirk van den Boom, et al.. (1998). Application of nested PCR and mass spectrometry for DNA-based virus detection: HBV-DNA detected in the majority of isolated anti-HBc positive sera. Genetic Analysis Biomolecular Engineering. 14(3). 97–102. 14 indexed citations
18.
Lunzen, Jan van, F. Hufert, Bernhard Zöllner, et al.. (1997). Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells. AIDS. 11(9). 1103–1110. 32 indexed citations
19.
Zöllner, Bernhard, H.-H. Feucht, Rainer Laufs, et al.. (1993). Isolation ofChlamydia trachomatis from the lower digestive tract. Infection. 21(5). 318–320. 6 indexed citations
20.
Zöllner, Bernhard & H Wuthe. (1993). Lior-serotype variants in Campylobacter isolates from the same stool sample. Journal of Medical Microbiology. 38(1). 3–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Marie Huraux Breakdown of academic impact, for papers by Moya Briggs Breakdown of academic impact, for papers by George G. Schlauder Breakdown of academic impact, for papers by Jacqueline C. Melpolder Breakdown of academic impact, for papers by G. L. Toms Breakdown of academic impact, for papers by K. Krawczyński Breakdown of academic impact, for papers by H. J. Alter Breakdown of academic impact, for papers by Yoshiki Sugai Breakdown of academic impact, for papers by Benoît Callendret Breakdown of academic impact, for papers by Hajime Tokita
Rankless by CCL
2026